NVG-291 is indeed a therapeutic peptide designed as a derivative of the protein region responsible for nerve growth inhibition. By targeting specific receptor pathways and neutralizing the inhibitory molecules that prevent nerve repair within the central nervous system, this proprietary peptide promotes structural plasticity and functional neural reconnection.